Delays in FDA approval of a vaccine probably won’t change when most of us get a vaccine. PFE says it might be able to seek approval by end of Nov, so Dec approval possible. But will only have 100M doses ready by YE (50M courses). So unless you have... nytimes.com/2020/10/16/hea…
So unless you have reason to think you would be among the 50M first up to get vaccinated, what will determine when you get vaccinated is the pace of production. & for most of us, our ticket likely won’t be called until 2Q21. So approval delays of 1-2 months won’t change that.
You might even prefer that the vaccines be vetted more carefully. Of course, the people who would be impacted by delays are those slated to get the first doses. Front-line workers, vulnerable. They too might prefer to know the vaccines are safe and effective.
And while it’s very important to protect our front-line workers & vulnerable ASAP for their sake & therefore efficient approval is important of even the few doses companies have built up... that won’t open up the economy (ie economy doesn’t open when vaccine is approved!).
Opening economy will require majority to get vaccinated, which is a function of production, not speed of approval. When there are 500M (& growing) doses stockpiled & ready to go (~Feb) but we still don’t have approval, that’s when approval becomes rate limiting to econ opening.
Our team is tracking how many doses we think various companies will have available for various regions over time on our Covid Vaccine map (lower right). Major early contributor could be AZ, but they are on hold in US & have weakest vaccine, so big unknown. racap.com/covid-19
• • •
Missing some Tweet in this thread? You can try to
force a refresh
